|Systematic (IUPAC) name|
|Mol. mass||247.25 g/mol|
Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely-used NRTI, meaning that the two compounds are mirror images of each other.
- "Racivir". AIDSmeds.com. March 24, 2006. Retrieved March 21, 2008.
|This antiinfective drug article is a stub. You can help Wikipedia by expanding it.|